$20.66
-3.1%Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
Strong liquidity. The company has adequate resources to meet short-term liabilities.
Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.
Strong working capital position provides significant operational flexibility and financial cushion.
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
PRVA โข NASDAQ
| Privia Health Group, Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
479.7M | 491.1M | 389.5M | 348M | 320.6M | 84.6M | 46.9M | 39.1M | |
479.7M | 491.1M | 389.5M | 348M | 320.6M | 84.6M | 46.9M | 39.1M | |
400.9M | 316.2M | 290.8M | 189.6M | 117.4M | 99.1M | 77.3M | 71.2M | |
400.9M | 316.2M | 290.8M | 189.6M | 117.4M | 99.1M | 77.3M | 71.2M | |
0.0 | 0.0 | 0.0 | 0.0 | 8.7M | 6.3M | 5.4M | 5.2M | |
30.4M | 27.5M | 20.5M | 14.4M | 0.0 | 0.0 | 0.0 | 0.0 | |
911M | 834.8M | 700.8M | 552M | 446.7M | 190.1M | 129.6M | 115.5M | |
NON-CURRENT ASSETS | ||||||||
9.3M | 6.1M | 8.9M | 11.5M | 14.1M | 4.8M | 5.6M | 698K | |
209.8M | 141.6M | 138.7M | 126.9M | 127.9M | 118.7M | 118.7M | 118.7M | |
215.9M | 109.8M | 107.6M | 57.4M | 59.7M | 6M | 6.6M | 7.3M | |
425.8M | 251.4M | 246.4M | 184.3M | 187.7M | 124.6M | 125.3M | 125.9M | |
2.3M | 26.4M | 35.2M | 40.4M | 33.4M | 5M | 0.0 | 0.0 | |
21M | 17.1M | 8.6M | 4.7M | 4.5M | 4.5M | 9.7M | 7.4M | |
458.4M | 301M | 299.1M | 240.9M | 239.7M | 138.9M | 140.6M | 134M | |
1.4B | 1.1B | 999.9M | 792.8M | 686.4M | 329M | 270.2M | 249.5M | |
LIABILITIES | ||||||||
CURRENT LIABILITIES | ||||||||
8M | 30.2M | 23M | 21.9M | 15.3M | 15.7M | 9.4M | 4.7M | |
8M | 9.8M | 7.9M | 6.7M | 3M | 5.2M | 525K | 4.7M | |
0.0 | 20.4M | 15.1M | 15.2M | 12.3M | 10.4M | 8.8M | 0.0 | |
55.3M | 45.8M | 28.9M | 24.7M | 23.2M | 17.4M | 15.6M | 85.1M | |
0.0 | 0.0 | 0.0 | 0.0 | 875K | 875K | 3.4M | 7.1M | |
2.2M | 2.6M | 3M | 3M | 2.9M | 0.0 | 0.0 | 0.0 | |
503.1M | 370.6M | 332.1M | 214.6M | 148.2M | 113M | 86.9M | 4.4M | |
568.5M | 449.1M | 387M | 264.3M | 190.5M | 146.9M | 115.2M | 101.3M | |
NON-CURRENT LIABILITIES | ||||||||
0.0 | 0.0 | 0.0 | 0.0 | 31.7M | 32.8M | 39.7M | 59.9M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9M | 0.0 | |
2.6M | 153K | 313K | 1M | 3M | 5.6M | 4.9M | 2.3M | |
9.9M | 3.2M | 5.6M | 9.5M | 45.7M | 38.4M | 47.5M | 62.1M | |
9.5M | 5.6M | 8.3M | 11.5M | 13.9M | 0.0 | 0.0 | 0.0 | |
578.4M | 452.3M | 392.5M | 273.8M | 236.2M | 185.3M | 162.7M | 163.4M | |
SHAREHOLDERS' EQUITY | ||||||||
1.2M | 1.2M | 1.2M | 1.1M | 1.1M | 960K | 959K | 959K | |
892.3M | 813.2M | 753.9M | 714.6M | 633.9M | 165.7M | 160.4M | 146.9M | |
-156.3M | -179.2M | -193.6M | -216.7M | -208.1M | -19.9M | -51.1M | -59.4M | |
737.2M | 635.2M | 561.4M | 499.1M | 426.9M | 146.7M | 110.2M | 88.5M | |
790.9M | 683.4M | 607.4M | 519M | 450.2M | 143.7M | 107.5M | 86M | |
53.7M | 48.3M | 46M | 20M | 23.3M | -3.1M | -2.8M | -2.5M | |
SUMMARY | ||||||||
1.4B | 1.1B | 999.9M | 792.8M | 686.4M | 329M | 270.2M | 249.5M | |
9.5M | 5.6M | 8.3M | 11.5M | 46.5M | 33.7M | 43.1M | 67M | |
-470.2M | -485.6M | -381.2M | -336.5M | -274.1M | -51M | -3.8M | 27.9M | |
123,001,529 | 123,001,529 | 123,001,529 | 123,001,529 | 123,001,529 | 123,001,529 | 123,001,529 | 123,001,529 |
PRVA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 22, 2026 | May 20, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 02, 2026 | May 20, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 08, 2025 | December 05, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 28, 2025 | October 24, 2025 | 2025 |
Continue your PRVA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.